About AUPH Dividend Returns
Aurinia Pharmaceuticals Inc. (AUPH) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of AUPH over the past year?
Aurinia Pharmaceuticals Inc. (AUPH) delivered a return of 78.24% over the past year. Since AUPH does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in AUPH be worth today?
A $10,000 investment in Aurinia Pharmaceuticals Inc. one year ago would be worth $17,824 today, representing a gain of $7,824.
Q3Does AUPH pay dividends?
Aurinia Pharmaceuticals Inc. (AUPH) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For AUPH, the total return equals the price-only return.
Q4Did AUPH beat the S&P 500?
Yes, Aurinia Pharmaceuticals Inc. (AUPH) outperformed the S&P 500 by 62.79 percentage points over the past year. AUPH delivered a total return of 78.24%, compared to the S&P 500's 15.45%. This 62.79pp alpha means investors in AUPH earned more than a passive S&P 500 index fund.
Q5What is AUPH's worst drawdown?
Aurinia Pharmaceuticals Inc. (AUPH) experienced a maximum drawdown of -16.96% over the past year, declining from its peak on 2025-03-25 to its trough on 2025-04-08. The stock recovered to its prior peak by 2025-07-10. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is AUPH's long-term total return over 10, 20, or 30 years?
Aurinia Pharmaceuticals Inc. (AUPH) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 497.9% (19.6% CAGR) — $10,000 would have grown to $59,789. Over 20 years: 263.3% total return (6.7% CAGR) — $10,000 → $36,334. Over 30 years: 263.3% total return (4.4% CAGR) — $10,000 → $36,333. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was AUPH's best and worst year?
Aurinia Pharmaceuticals Inc.'s best calendar year was 2019 with a total return of 196.2%. Its worst year was 2022 with a total return of -80.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 277.0 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).